PaxMedica Inc Share Price Today: Live Updates & Key Insights
PaxMedica Inc share price today is $0.6957, up -6.62%. The stock opened at $0.76 against the previous close of $0.745, with an intraday high of $0.76 and low of $0.65.
PaxMedica Inc Share Price Chart
PaxMedica Inc
PaxMedica Inc Share Price Performance
PaxMedica Inc Institutional Holdings
PaxMedica Inc Market Status
PaxMedica Inc Fundamentals
Market Cap 5.53 M
PB Ratio 1.835
PE Ratio 0.0
Enterprise Value 0.78 M
Total Assets 5.68 M
Volume 234684
PaxMedica Inc Company Financials
About PaxMedica Inc & investment objective
Company Information PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies for the treatment of disorders with intractable neurologic symptoms. Its lead product candidate is PAX-101 that is in Phase 3 clinical trials, an intravenous formulation of suramin for the treatment of autism spectrum disorder, myalgic encephalomyelitis/chronic fatigue syndrome, long COVID-19 syndrome, fragile X syndrome, human African trypanosomiasis (HAT), and fragile X-associated tremor/ataxia syndrome. The company is developing PAX-102, an intranasal formulation of suramin for neurologic indications, as well as other new chemical entities that are targeted and selective antagonists of purine receptor subtypes; and PAX-HAT-301 for the treatment of HAT. It has a research collaboration agreement with PolarMar Health for Phase II clinical trial in austism spectrum disorder for emodin, which retains the rights for PolarMar to develop and commercialize any non-prescription supplement form of the product, and for PaxMedica, Inc. to retain exclusive rights to develop and commercialize a highly purified form of emodin. The company was formerly known as Purinix Pharmaceuticals LLC and changed its name to PaxMedica, Inc. in April 2020. PaxMedica, Inc. was incorporated in 2018 and is based in Tarrytown, New York.
Organisation Biotechnology
Employees 6
Industry Biotechnology
CEO Mr. Howard J. Weisman
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
PaxMedica Inc FAQs
What is the share price of PaxMedica Inc today?
The current share price of PaxMedica Inc is $0.6957.
Can I buy PaxMedica Inc shares in India?
Yes, Indian investors can buy PaxMedica Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy PaxMedica Inc shares in India?
You can easily invest in PaxMedica Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy PaxMedica Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of PaxMedica Inc.
Can I buy fractional shares of PaxMedica Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of PaxMedica Inc?
PaxMedica Inc has a market cap of $5.53 M.
In which sector does PaxMedica Inc belong?
PaxMedica Inc operates in the Biotechnology sector.
What documents are required to invest in PaxMedica Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of PaxMedica Inc?
The PE ratio of PaxMedica Inc is N/A and the PB ratio is 1.84.